Advanced search
Publication Cover
Cancer Investigation Volume 25, 2007 - Issue 1
Submit an article Journal homepage
163
Views
40
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Quantitative Analysis of Breast Cancer Tissue Microarrays Shows High Cox-2 Expression Is Associated with Poor Outcome

Maciej P. Zerkowski Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA
, B.S.,
Robert L. Camp Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA
, M.D., Ph.D.,
Barbara A. Burtness Yale Cancer Center and Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut, USA
, M.D.,
David L. Rimm Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA
, M.D., Ph.D. &
Gina G. Chung Yale Cancer Center and Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut, USA
, M.D.
Pages 19-26 | Published online: 11 Jun 2009

REFERENCES

  • Rolland P. H., Martin P. M., Jacquemier J., Rolland A. M., Toga M. Prostaglandin in human breast cancer: evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J. Natl. Cancer Inst. 1980; 64: 1061–1070
  • Thun M. J., Namboodiri M. M., Heath C. W., Jr. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med. 1991; 325: 1593–1596
  • Giovannucci E., Rimm E. B., Stampfer M. J., Colditz G. A., Ascherio A., Willett W. C. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann. Intern. Med. 1994; 121: 241–246
  • Khuder S. A., Mutgi A. B. Breast cancer and NSAID use: a meta-analysis. Br. J. Cancer 2001; 84: 1188–1192
  • Ristimaki A., Sivula A., Lundin J. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res. 2002; 62: 632–635
  • Half E., Tang X. M., Gwyn K., Sahin A., Wathen K., Sinicrope F. A. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res. 2002; 62: 1676–1681
  • Oshima M., Murai N., Kargman S. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res. 2001; 61: 1733–1740
  • Oshima M., Dinchuk J. E., Kargman S. L. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803–809
  • Liu C. H., Chang S. H., Narko K. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J. Biol. Chem. 2001; 276: 18563–18569
  • Chang S. H., Liu C. H., Conway R. Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proc. Natl. Acad. Sci. USA 2004; 101: 591–596
  • Camp R. L., Chung G. G., Rimm D. L. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat. Med. 2002; 8: 1323–1327
  • Camp R. L., Dolled-Filhart M., Rimm D. L. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin. Cancer Res. 2004; 10: 7252–7259
  • DiVito K. A., Charette L. A., Rimm D. L., Camp R. L. Long-term preservation of antigenicity on tissue microarrays. Lab. Invest. 2004; 84: 1071–1078
  • Wulfing P., Diallo R., Muller C. Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis. J. Cancer. Res. Clin. Oncol. 2003; 129: 375–382
  • Lim S. C. Role of COX-2, VEGF and cyclin D1 in mammary infiltrating duct carcinoma. Oncol. Rep. 2003; 10: 1241–1249
  • Spizzo G., Gastl G., Wolf D. Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival. Br. J. Cancer 2003; 88: 574–578
  • Denkert C., Winzer K. J., Muller B. M. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma. Cancer 2003; 97: 2978–2987
  • Brueggemeier R. W., Richards J. A., Petrel T. A. Aromatase and cyclooxygenases: enzymes in breast cancer. J. Steroid. Biochem. Mol. Biol. 2003; 86: 501–507
  • Subbaramaiah K., Norton L., Gerald W., Dannenberg A. J. Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3. J. Biol. Chem. 2002; 277: 18649–18657

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.